- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05841979
The Lived Experiences Measured Using Rings Pilot Study (LEMURS-P)
April 14, 2025 updated by: Matthew Price, University of Vermont
The transition to college is a period of elevated risk for a range of mental health conditions.
For students with pre-existing mental health diagnoses, the added pressures can exacerbate challenges.
Although colleges and universities strive to provide mental health support to their students, the high demand for these services makes it difficult to provide scalable cost-effective solutions.
To address these issues, the present study aims to compare the efficacy of three different treatments using a large cohort of 600 students transitioning to college.
Interventions were selected based on their potential for generalizability and cost-effectiveness on college campuses.
The randomized controlled trial will assign 150 participants to one of four arms: 1) group-based therapy, 2) physical activity program, 3) nature experiences group, or 4) self-monitoring condition as the control group.
In addition, biometric data will be collected from all participants using a wearable device to develop algorithmic predictions of mental and physical health functioning.
Once recruitment is complete, modeling strategies will be used to evaluate the outcomes and effectiveness of each intervention.
The findings of this study will provide evidence as to the benefits of implementing scalable and proactive interventions using technology with the goal of improving well-being and success of new college students.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
188
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vermont
-
Burlington, Vermont, United States, 05405
- University of Vermont
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current undergraduate student in their first year of school
- own a mobile device
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: group-based therapy
Group therapy delivered via moodlifters
|
Mood Lifters, a novel mental wellness program, was developed as a more accessible means to provide psychotherapy (Votta & Deldin, 2022).
Meetings covered biopsychosocial areas and skills that were drawn from multiple therapeutic interventions consistent with a biopsychosocial framework.
Areas included physical health, negative thoughts, problem-solving, emotional awareness and regulation, building relationships, behavioral activation, and using a strengths-based approach.
ML is delivered by peer leaders who are individuals that have completed the program as well as a training program.
|
|
Experimental: physical activity
Physical Activity and Exercise
|
Participants randomized to the exercise arm received 14 weeks of a structured weekly strength and conditioning training program to enhance muscle mass, strength, cardiorespiratory fitness, and overall well-being.
The program is based on previous research showing that cardiorespiratory fitness and muscle strength/size can both contribute to decreased mortality/increased longevity and enhanced mental health (Burke et al., 2017; McLeod et al., 2016; Srikanthan & Karlamangla, 2014; Strasser & Burtscher, 2018).
The training program consists of three training sessions per week, with one being an in-person group session guided by a certified strength and conditioning specialist.
The other two training sessions are self-guided via the mobile app Trainheroic.
This weekly training schedule aligns with previous research showing benefits to structuring an exercise program using a variety of social contexts (group setting, own, etc.; Burke et al., 2017).
|
|
Experimental: nature experience
Nature Experiences
|
Participants randomized to the Nature Experiences participated in 14 weeks of group and self-directed activities to connect with the natural environment.
Weekly group activities will be led by Nature Guides, who are undergraduate and graduate students with extensive outdoor education training.
Group activities will last one hour a week and include hiking in forests, walking in parks, bird-watching, mindfulness exercises, and snow activities.
Participants will be given a list of self-directed activity suggestions each week.
The goal of self-directed activities is to spend an additional two hours in a natural environment each week.
|
|
No Intervention: self-monitoring
Placebo control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression as measured by Depression, Anxiety, Stress Survey - 21 (Depression subscale)
Time Frame: Change in depression scores from time of randomization through 5 months
|
Self Reported Depression
|
Change in depression scores from time of randomization through 5 months
|
|
Anxiety as measured by Depression, Anxiety, Stress Survey - 21 (Anxiety subscale)
Time Frame: Change in anxiety scores from time of randomization through 5 months
|
Self ReportedAnxiety
|
Change in anxiety scores from time of randomization through 5 months
|
|
Stress as measured by Depression, Anxiety, Stress Survey - 21 (Stress subscale)
Time Frame: Change in stress scores from time of randomization through 5 months
|
Self Reported Stress
|
Change in stress scores from time of randomization through 5 months
|
|
Well-Being as measured by Warwick-Edinburgh Mental Well-being Scale
Time Frame: Change in well-being scores from time of randomization through 5 months
|
Self Reported well-being
|
Change in well-being scores from time of randomization through 5 months
|
|
Stress as measured by the Perceived Stress Scale
Time Frame: Change in stress scores from time of randomization through 5 months
|
Self Reported subclinical stress
|
Change in stress scores from time of randomization through 5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Quality Index
Time Frame: Change in sleep quality scores from time of randomization through 5 months
|
Self Reported Sleep
|
Change in sleep quality scores from time of randomization through 5 months
|
|
Oura Ring Sleep Index
Time Frame: Change in Oura Sleep measured scores from time of randomization through 5 months
|
Biometric Sleep recorded from an Oura Ring
|
Change in Oura Sleep measured scores from time of randomization through 5 months
|
|
Medical Outcomes Social Support Survey
Time Frame: Change in social support scores scores from time of randomization through 5 months
|
Social Support
|
Change in social support scores scores from time of randomization through 5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Laura Bloomfield, MD, PhD, University of Vermont
- Principal Investigator: Chris Danforth, PhD, University of Vermont
- Principal Investigator: Ryan McGinnis, PhD, University of Vermont
- Principal Investigator: Ellen McGinnis, PhD, University of Vermont
- Principal Investigator: Matthew Price, PhD, University of Vermont
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2022
Primary Completion (Actual)
June 1, 2024
Study Completion (Actual)
June 1, 2024
Study Registration Dates
First Submitted
April 6, 2023
First Submitted That Met QC Criteria
April 21, 2023
First Posted (Actual)
May 3, 2023
Study Record Updates
Last Update Posted (Actual)
April 17, 2025
Last Update Submitted That Met QC Criteria
April 14, 2025
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LEMURS S23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Moodlifters
-
University of MichiganCompleted